Abstract 4337522: Prognostic Impact of Right Ventricle-Pulmonary Artery Coupling in Patients with Severe Calcific Mitral Stenosis

Background: Right ventricular function is strongly associated with the mortality in mitral stenosis (MS). The ratio of tricuspid annular plane systolic excursion (TAPSE)/pulmonary artery systolic pressure (PASP) serves as a noninvasive measure of right ventricle-pulmonary artery (RV-PA) coupling, which reflects the ability of RV to handle a given pulmonary afterload. Our aim is to assess the relationship between TAPSE/PASP and outcomes in calcific MS. Methods: A single-center retrospective cohort study was performed. Patients diagnosed with calcific MS on echocardiography between October 2010 and August 2020 were identified. We included patients with severe calcific MS due to mitral annular calcification (MAC) who had TAPSE and PASP measurements available. Propensity score (PS) was performed using a logistic regression model, with TAPSE/PASP >0.45 as the dependent variable and seven clinically relevant covariates (age, sex, NYHA class, hypertension, atrial fibrillation, Charlson comorbidity index, left ventricular ejection fraction). After PS matching, we compared all-cause mortality between the two groups. Outcomes: Of 7,154 patients with MS, 229 patients with severe calcific MS were included (72 with TAPSE/PASP >0.45 and 157 with TAPSE/PASP ≤0.45). In the entire cohort, the mean age was 72 ± 11 years and 65.9% were female. During the median follow-up duration of 345 days (25 th -75 th percentile: 80 – 851 days), 80 patients (34.9%) underwent mitral valve surgery, and there were 74 (32.3%) deaths. The cumulative survival of patients with TAPSE/PASP ≤0.45 was lower than patients with TAPSE/PASP >0.45 in the entire cohort (p = 0.001), the conservative treatment group (p = 0.023), and the mitral valve intervention group (p = 0.020). After PS matching in 144 patients (72 patients in each group), similar results were obtained (p = 0.002, p = 0.028, p = 0.021). Conclusion: TAPSE/PASP is strongly associated with all-cause mortality in patients with severe calcific MS. This relationship was also observed after PS matching, suggesting this is a valuable non-invasive marker in calcific MS.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-11-03
DOI
https://doi.org/10.1161/circ.152.suppl_3.4337522
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4337522: Prognostic Impact of Right Ventricle-Pulmonary Artery Coupling in Patients with Severe Calcific Mitral Stenosis

Gösta Pettersson, Haytham Elgharably, Shinya Unai, Richard A. Grimm et al.
Circulation
Cardiac Valve Diseases and Treatments
article

Abstract 4337522: Prognostic Impact of Right Ventricle-Pulmonary Artery Coupling in Patients with Severe Calcific Mitral Stenosis

Gösta Pettersson, Haytham Elgharably, Shinya Unai, Richard A. Grimm, A. Marc Gillinov, Yuichiro Okushi, Brian P. Griffin, Bo Xu
article en

Abstract

Background: Right ventricular function is strongly associated with the mortality in mitral stenosis (MS). The ratio of tricuspid annular plane systolic excursion (TAPSE)/pulmonary artery systolic pressure (PASP) serves as a noninvasive measure of right ventricle-pulmonary artery (RV-PA) coupling, which reflects the ability of RV to handle a given pulmonary afterload. Our aim is to assess the relationship between TAPSE/PASP and outcomes in calcific MS. Methods: A single-center retrospective cohort study was performed. Patients diagnosed with calcific MS on echocardiography between October 2010 and August 2020 were identified. We included patients with severe calcific MS due to mitral annular calcification (MAC) who had TAPSE and PASP measurements available. Propensity score (PS) was performed using a logistic regression model, with TAPSE/PASP >0.45 as the dependent variable and seven clinically relevant covariates (age, sex, NYHA class, hypertension, atrial fibrillation, Charlson comorbidity index, left ventricular ejection fraction). After PS matching, we compared all-cause mortality between the two groups. Outcomes: Of 7,154 patients with MS, 229 patients with severe calcific MS were included (72 with TAPSE/PASP >0.45 and 157 with TAPSE/PASP ≤0.45). In the entire cohort, the mean age was 72 ± 11 years and 65.9% were female. During the median follow-up duration of 345 days (25 th -75 th percentile: 80 – 851 days), 80 patients (34.9%) underwent mitral valve surgery, and there were 74 (32.3%) deaths. The cumulative survival of patients with TAPSE/PASP ≤0.45 was lower than patients with TAPSE/PASP >0.45 in the entire cohort (p = 0.001), the conservative treatment group (p = 0.023), and the mitral valve intervention group (p = 0.020). After PS matching in 144 patients (72 patients in each group), similar results were obtained (p = 0.002, p = 0.028, p = 0.021). Conclusion: TAPSE/PASP is strongly associated with all-cause mortality in patients with severe calcific MS. This relationship was also observed after PS matching, suggesting this is a valuable non-invasive marker in calcific MS.

CirculationVol. 152(Suppl_3)
Cleveland Clinic (US)
Openalex Percentile: Top 50%
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.